Patients
Healthcare wants patients at the centre. So, why are they st...
Claire Gillis reflects on a surprising controversy at ESMO 2026, and the uncomfortable questions it raises for healthcare.
Digital
The growing use of synthetic data in modern pharma
The issue isn't whether synthetic data is useful. It is what question we are asking it to answer.
R&D
Europe’s growing vector-borne disease threat: Are we keeping...
In Europe, diseases once largely associated with tropical or subtropical regions are becoming a more immediate concern.
R&D
Kidney care raises its ambitions at ASN Kidney Week 2026
Following ASN Kidney Week 2026, pharmaphorum spoke with Hansa Biopharma's Maria Törnsén and Tes Pharma's Andrea Pellacani about the conference.
Oncology
Lung cancer vaccine renews synthetic DNA discussions
pharmaphorum spoke with Dr Amy Walker, CEO of 4basebio, about personalised cancer vaccines and synthetic DNA.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
